
Congrats to Chris Ladaika for his first author publication in Molecular Cancer Research!
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a new potential therapeutic target for colorectal cancers with BRAF gene mutations, which occur in about 10% of metastatic colorectal cancers. Their findings, recently published in Molecular Cancer, provide new insights for addressing treatment-resistance to improve responses to cancer therapies.